VSTM: Verastem, Inc.
Performance
VSTM +7.81%
Watchlist
Select an item
Summary
VSTM at a glance
VSTM returned +7.81% over the past year and -23.35% a year over five years. Its worst drop in that year was -67.58%, smaller than 7% of stocks on Redstone, and its Sharpe ratio of 0.42 beats 46% of stocks on Redstone. It pays no dividends.
Current Drawdown
-18.23%
Rolling Volatility
101.08%
Actions
Metrics
Risk Indicators
Alpha22.03%
Beta0.87x
Sharpe0.42
Sortino0.64
Omega1.07
Calmar0.12
Martin0.76
Profile
About VSTM
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.1B
- Listed
- Jan 2012
- Employees
- 102
- Headquarters
- Needham, MA
- Website
- verastem.com
Comparisons